Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2021 Jul 1;181(7):960-966.
doi: 10.1001/jamainternmed.2021.2114.

SARS-CoV-2 Transmission Risk Among National Basketball Association Players, Staff, and Vendors Exposed to Individuals With Positive Test Results After COVID-19 Recovery During the 2020 Regular and Postseason

Affiliations
Multicenter Study

SARS-CoV-2 Transmission Risk Among National Basketball Association Players, Staff, and Vendors Exposed to Individuals With Positive Test Results After COVID-19 Recovery During the 2020 Regular and Postseason

Christina D Mack et al. JAMA Intern Med. .

Abstract

Importance: Clinical data are lacking regarding the risk of viral transmission from individuals who have positive reverse-transcription-polymerase chain reaction (RT-PCR) SARS-CoV-2 test results after recovery from COVID-19.

Objective: To describe case characteristics, including viral dynamics and transmission of infection, for individuals who have clinically recovered from SARS-CoV-2 infection but continued to have positive test results following discontinuation of isolation precautions.

Design, setting, and participants: This retrospective cohort study used data collected from June 11, 2020, to October 19, 2020, as part of the National Basketball Association (NBA) closed campus occupational health program in Orlando, Florida, which required daily RT-PCR testing and ad hoc serological testing for SARS-CoV-2 IgG antibodies. Nearly 4000 NBA players, staff, and vendors participated in the NBA's regular and postseason occupational health program in Orlando. Persistent positive cases were those who recovered from a documented SARS-CoV-2 infection, satisfied US Centers for Disease Control and Prevention criteria for discontinuation of isolation precautions, and had at least 1 postinfection positive RT-PCR test(s) result.

Exposures: Person-days of participation in indoor, unmasked activities that involved direct exposure between persistent positive cases and noninfected individuals.

Main outcomes and measures: Transmission of SARS-CoV-2 following interaction with persistent positive individuals, as measured by the number of new COVID-19 cases in the Orlando campus program.

Results: Among 3648 individuals who participated, 36 (1%) were persistent positive cases, most of whom were younger than 30 years (24 [67%]) and male (34 [94%]). Antibodies were detected in 33 individuals (91.7%); all remained asymptomatic following the index persistent positive RT-PCR result. Cycle threshold values for persistent positive RT-PCR test results were typically above the Roche cobas SARS-CoV-2 limit of detection. Cases were monitored for up to 100 days (mean [SD], 51 [23.9] days), during which there were at least 1480 person-days of direct exposure activities, with no transmission events or secondary infections of SARS-CoV-2 detected (0 new cases).

Conclusions and relevance: In this retrospective cohort study of the 2020 NBA closed campus occupational health program, recovered individuals who continued to test positive for SARS-CoV-2 following discontinuation of isolation were not infectious to others. These findings support time-based US Centers of Disease Control and Prevention recommendations for ending isolation.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Drs Mack and Tai and Ms Shiue reported being employees of IQVIA, which is in a paid consultancy with NBA, during the conduct of the study. Dr DiFiori reported consulting fees from the NBA outside the submitted work. Dr Grad reported personal fees from the NBA during the conduct of the study and grants from Merck and Pfizer and personal fees from GlaxoSmithKline outside the submitted work. Dr Anderson reported consulting fees from the NBA Players Association Fees during the conduct of the study as well as grants from the US Centers for Disease Control and Prevention (CDC), National Institutes of Health/National Institute of Allergy and Infectious Diseases, and the Agency for Healthcare Research and Quality, personal fees from UpToDate, and being a co-owner of Infection Control Education for Major Sports, LLC. Dr Mancell reported personal fees from the NBA during the conduct of the study and is a team physician for the Memphis Grizzlies. Dr Maragakis reported serving as cochair of the Healthcare Infection Control Practices Advisory Committee for the CDC. No other disclosures were reported.

Figures

Figure.
Figure.. Test Results Among 36 Individuals Who Recovered From COVID-19 With Persistent Positive SARS-CoV-2 Reverse-Transcription–Polymerase Chain Reaction (RT-PCR) Tests
The longitudinal pattern of test results across recovered individuals who continued to test positive differed greatly with some individuals who experienced large stretches of negative test results without any positive test results, while others had more frequent intermittent positive tests. Recovered persistent/recurrent positive designation was based on clinician diagnosis using standardized operational definitions. The index date (day 0) was defined as the date of the first positive or inconclusive RT-PCR test result occurred after isolation had been discontinued. The RT-PCR test results shown were run primarily on the Roche cobas platform; results from the Hologic Panther platform was used before arrival in Orlando, Florida, and in 1 rare occasion in Orlando when the Roche cobas platform was not available (this applies only to case number 25).

Comment in

Similar articles

Cited by

References

    1. Vibholm LK, Nielsen SSF, Pahus MH, et al. . SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses. EBioMedicine. 2021;64:103230. doi:10.1016/j.ebiom.2021.103230 - DOI - PMC - PubMed
    1. Wu J, Liu X, Liu J, et al. . Coronavirus disease 2019 test results after clinical recovery and hospital discharge among patients in China. JAMA Netw Open. 2020;3(5):e209759. doi:10.1001/jamanetworkopen.2020.9759 - DOI - PMC - PubMed
    1. Wu Y, Guo C, Tang L, et al. . Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol. 2020;5(5):434-435. doi:10.1016/S2468-1253(20)30083-2 - DOI - PMC - PubMed
    1. Hartman WR, Hess AS, Connor JP. Persistent viral RNA shedding after COVID-19 symptom resolution in older convalescent plasma donors. Transfusion. 2020;60(10):2189-2191. doi:10.1111/trf.15927 - DOI - PMC - PubMed
    1. Zhang B, Liu S, Dong Y, et al. . Positive rectal swabs in young patients recovered from coronavirus disease 2019 (COVID-19). J Infect. 2020;81(2):e49-e52. doi:10.1016/j.jinf.2020.04.023 - DOI - PMC - PubMed

Publication types

Substances